PubRank

Jae Hyung Noh

Author PubWeight™ 48.05‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Phase III trial comparing capecitabine plus cisplatin versus capecitabine plus cisplatin with concurrent capecitabine radiotherapy in completely resected gastric cancer with D2 lymph node dissection: the ARTIST trial. J Clin Oncol 2011 4.11
2 An observational study suggesting clinical benefit for adjuvant postoperative chemoradiation in a population of over 500 cases after gastric resection with D2 nodal dissection for adenocarcinoma of the stomach. Int J Radiat Oncol Biol Phys 2005 2.19
3 Predictive factors for lymph node metastasis in early gastric cancer with submucosal invasion: analysis of a single institutional experience. Ann Surg 2007 1.74
4 The difficult choice between total and proximal gastrectomy in proximal early gastric cancer. Am J Surg 2008 1.66
5 Impact of MET amplification on gastric cancer: possible roles as a novel prognostic marker and a potential therapeutic target. Oncol Rep 2011 1.66
6 Clinical significance of splenic hilar lymph node metastasis in proximal gastric cancer. Ann Surg Oncol 2009 1.23
7 Recurrence after curative resection of early gastric cancer. Ann Surg Oncol 2009 1.19
8 Borrmann type IV: an independent prognostic factor for survival in gastric cancer. J Gastrointest Surg 2008 1.14
9 Changes of quality of life in gastric cancer patients after curative resection: a longitudinal cohort study in Korea. Ann Surg 2012 1.11
10 Bronchogenic cyst of the stomach masquerading as benign stromal tumor. Pathol Int 2005 1.08
11 Nutritional risk index as a predictor of postoperative wound complications after gastrectomy. World J Gastroenterol 2012 1.03
12 Proposal to subclassify stage IV gastric cancer into IVA, IVB, and IVM. Arch Surg 2009 1.02
13 Prognostic stratification of high-risk gastrointestinal stromal tumors in the era of targeted therapy. Ann Surg 2008 1.01
14 Prognostic role of p-mTOR expression in cancer tissues and metastatic lymph nodes in pT2b gastric cancer. Int J Cancer 2010 0.98
15 Impact of E2F-1 expression on clinical outcome of gastric adenocarcinoma patients with adjuvant chemoradiation therapy. Clin Cancer Res 2008 0.97
16 Expression of activated signal transducer and activator of transcription 3 predicts poor clinical outcome in gastric adenocarcinoma. APMIS 2009 0.97
17 A new suggestion for the radiation target volume after a subtotal gastrectomy in patients with stomach cancer. Int J Radiat Oncol Biol Phys 2008 0.96
18 The relationships between perioperative CEA, CA 19-9, and CA 72-4 and recurrence in gastric cancer patients after curative radical gastrectomy. J Surg Oncol 2011 0.95
19 Mucinous gastric cancer presents with more advanced tumor stage and weaker β-catenin expression than nonmucinous cancer. Ann Surg Oncol 2010 0.95
20 Surgical outcome of synchronous second primary cancer in patients with gastric cancer. Yonsei Med J 2007 0.95
21 Laparoscopy-assisted distal gastrectomy in a patient with early gastric cancer and polysplenia. Surg Laparosc Endosc Percutan Tech 2012 0.93
22 Expression levels of cyclin G2, but not cyclin E, correlate with gastric cancer progression. J Surg Res 2008 0.91
23 Clinical significance of gastritis cystica profunda and its association with Epstein-Barr virus in gastric cancer. Cancer 2012 0.90
24 Cyclooxygenase-2 is an independent prognostic factor in gastric carcinoma patients receiving adjuvant chemotherapy and is not associated with EBV infection. Clin Cancer Res 2009 0.89
25 Adenocarcinoma derived from gastric hamartomatous polyps. J Korean Surg Soc 2011 0.88
26 Changes in postoperative recurrence and prognostic risk factors for patients with gastric cancer who underwent curative gastric resection during different time periods. Ann Surg Oncol 2013 0.88
27 Long-term results and prognostic factors of gastric cancer patients with only positive peritoneal lavage cytology. J Surg Oncol 2011 0.87
28 Phase I study of neoadjuvant chemoradiotherapy with S-1 and oxaliplatin in patients with locally advanced gastric cancer. Cancer Chemother Pharmacol 2012 0.87
29 Stapling technique for performing Billroth II anastomosis after distal gastrectomy. J Gastrointest Surg 2010 0.86
30 Omentum-preserving gastrectomy for early gastric cancer. World J Surg 2008 0.86
31 Clinical significance of tumor location in remnant gastric cancers developed after partial gastrectomy for primary gastric cancer. J Gastrointest Surg 2007 0.86
32 Radiofrequency ablation for hepatic metastasis from gastric adenocarcinoma. Yonsei Med J 2008 0.85
33 The outcome of patients with remnant primary gastric cancer compared with those having upper one-third gastric cancer. Am J Surg 2007 0.84
34 Early gastric cancer arising from heterotopic gastric mucosa in the gastric submucosa. J Korean Surg Soc 2011 0.84
35 Frequency and predictive factors of lymph node metastasis in mucosal cancer. J Gastric Cancer 2010 0.83
36 Validation of seventh edition AJCC gastric cancer staging modifications. J Surg Oncol 2011 0.83
37 Clinical significance of ghrelin concentration of plasma and tumor tissue in patients with gastric cancer. J Surg Res 2007 0.82
38 Tumor size predicts survival in mucinous gastric carcinoma. J Surg Oncol 2012 0.80
39 Ultrasonically activated shears versus electrocautery in open gastrectomy for gastric cancer: a randomized controlled trial. Gastric Cancer 2013 0.80
40 Stage IV early gastric cancer: two cases with microsatellite instability. Langenbecks Arch Surg 2007 0.80
41 Phase I study of intraperitoneal irinotecan in patients with gastric adenocarcinoma with peritoneal seeding. Cancer Chemother Pharmacol 2010 0.80
42 Clinical significance of the discrepancy between preoperative and postoperative diagnoses in gastric cancer patients. J Surg Oncol 2010 0.80
43 The prognosis of gastric cardia cancer after R0 resection. Am J Surg 2009 0.79
44 EBV infection and mismatch repair deficiency mediated by loss of hMLH1 expression contribute independently to the development of multiple synchronous gastric carcinomas. J Surg Oncol 2012 0.79
45 Impact of body mass index on surgical outcomes in radical total gastrectomy. Hepatogastroenterology 2012 0.78
46 Endoscopists' view on superficial spreading type of early gastric cancer--endoscopic resection or surgery? Scand J Gastroenterol 2010 0.77
47 The benefits of supplementary private health insurance for healthcare utilization and survival among stomach cancer patients. Tohoku J Exp Med 2009 0.76
48 The clue of Interstitial Cell of Cajalopathy (ICCpathy) in human diabetic gastropathy: the ultrastructural and electrical clues of ICCpathy in human diabetic gastropathy. Exp Toxicol Pathol 2010 0.76
49 EBV-associated lymphoepithelioma-like gastric carcinoma in a patient with HIV. Pathology 2009 0.76
50 The predictors and clinical impact of positive resection margins on frozen section in gastric cancer surgery. J Gastric Cancer 2012 0.75
51 Missed lesions in synchronous multiple gastric cancer. ANZ J Surg 2010 0.75
52 Circular stapler size and risk of anastomotic complications in gastroduodenostomy for gastric cancer. World J Surg 2012 0.75